1. Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma;Joerger,2012
2. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia;Csordas,2013
3. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies;Suthandiram,2014
4. Outcomes associated with reducing the urine alkalinization threshold in patients receiving high-dose methotrexate;Drost,2017
5. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL);Bergner,2012